This $10B Texas Startup Wants to Bring Back Extinct Animals Through Gene-Editing

This $10B Texas Startup Wants to Bring Back Extinct Animals Through Gene-Editing

The woolly mammoth could be brought back from extinction in just three years’ time—that is, if everything goes to plan over at Colossal Biosciences, a biotech startup looking to resurrect a select number of animal species that no longer roam our Earth. Founded in 2021, the company’s eye-catching “de-extinction” mission has caught the attention of scientists, conservationists and deep-pocketed investors. It’s managed to raise $435 million in fund…

Colossal Biosciences raises $200M at $10.2B valuation to revive woolly mammoths and other extinct species - Tech Startups

In a fitting move for a company focused on bringing extinct species back to life, Dallas-based Colossal Biosciences has raised $200 million in Series C funding, becoming Texas’ first “decacorn,” a term for private companies valued at over $10 billion. […] The post Colossal Biosciences raises $200M at $10.2B valuation to revive woolly mammoths and other extinct species first appeared on Tech Startups.

Colossal Biosciences raises $200M at $10.2B valuation to bring back woolly mammoths

Colossal Biosciences wants to bring back the woolly mammoth and has raised $200 million at a $10.2 billion valuation to do it.

It's trying to bring back the woolly mammoth — and it just got $200 million

Colossal Biosciences, the world’s first company dedicated to bringing back animals from extinction, has secured $200 million in series C funding. The latest investment announced Wednesday doubles the tech company’s total funding to $435 million since its 2021 launch, boosting the company’s valuation to $10.2 billion.Read more...

Australian company behind woolly mammoth meatballs axes 30 per cent of workforce

Cultured meat start-up Vow’s novel meat products have made headlines globally – but the company has hit a roadblock.

De-Extinction Startup Colossal Biosciences Hits Decacorn Status After $200M Raise

Colossal Biosciences, a de-extinction startup looking at ways to bring back the dodo bird and the woolly mammoth, raised a $200 million Series C at a $10.2 billion valuation. The new cash infusion came from TWG Global, a holding company jointly led by Mark Walter and Thomas Tull. The Dallas-based startup, which launched in 2021, plans to use the money to continue to advance its genetic engineering technologies, as well as grow its software and h…